Archive for April, 2014

NTI Draws Critical Support for Clinical Trials Network from Texas Lawmakers

Wednesday, April 30th, 2014

Following advocacy visits by National Trauma Institute officials, a delegation of Texas lawmakers sent a letter to the U.S. House Committee on Appropriations this month in support of federal funding for a national trauma research clinical trials network. The supporting legislators are the Honorable Lamar Smith, Joaquin Castro, Lloyd Doggett, Peter Gallego and Marc Veasey.

“A network of numerous trauma centers,” they wrote, “will be able to focus on critical research gaps…to supplement advances in care achieved over the past decade of combat operations, translate the lessons learned into the civilian community, and maintain the momentum in trauma research that could produce the same impact that funding of heart disease and cancer research has achieved.”

Read the letter.

National Trauma Institute Advocates for Congressional and Executive Branch Support

Monday, April 21st, 2014

NTI’s executive director, Sharon Smith, spent much of the last month meeting with legislators and federal agencies to lay out the case for funding trauma research at a sustainable level. The organization’s primary goal this year is to secure support for a trauma research repository and a clinical trials network—both essential to consolidation and coordination of a national trauma research agenda aimed at more effectively finding solutions to trauma’s largest clinical questions.

Smith, along with key NTI Board members, met with members of the White House Trauma Task Force, National Institutes of Health, Department of Homeland Defense, and Institute of Medicine as well as the legislative offices of Senator John Cornyn and Representatives Lamar Smith and Joaquin Castro.

Injectable Bandage May Offer Solution to Noncompressible Hemmorhage

Monday, April 14th, 2014

The Combat Casualty Care Research Program (CCCRP) has developed a relatively simple device to deal with a deadly problem: a syringe that injects bandages into deep injuries that cannot be treated with compression or tourniquets. So-called noncompressible hemmorhage is an NTI priority, as it is the primary cause of battlefield death related to potentially survivable injuries.

The device, called XSTAT contains small cellulose sponges that expand inside the wound, applying pressure from the inside to stop the bleeding. XSTAT recently received FDA approval and will be available commercially from manufacturer RevMedx. Read More.

New Cooling Technique May Stem Blood Loss

Monday, April 7th, 2014

According to a story reported in the Daily Beast, the University of Pittsburgh Medical Center will begin human trials using a super cooled electrolyte solution to slow blood loss in trauma patients when they don’t have time to get to a hospital before bleeding to death. Prior animal studies conducted at Massachusetts General Hospital and funded through the  Defense Advanced Research Projects Agency (DARPA), found that 90 percent of animals put into cold suspension could be revived with no loss of cognitive function.

Researchers don’t expect as positive a response in humans, since compounding factors in the study population–such as heart disease or diabetes–were not an issue. However, Sam Tischerman, who is heading the UPMC study, is cautiously optimistic: “Our hope is that we can save some people we can’t right now.”

“Methods to prevent deaths from blood loss are crucial, since about 85 percent of deaths on the battlefield are from bleeds medics can’t compress,” the article confirms. So-called non-compressible hemorrhage is one of the National Trauma Institute’s research priorities, and NTI was referenced in the story. Read the complete article.